Abrogating cholesterol esterification suppresses growth and metastasis of pancreatic cancer

Junjie Li(Purdue University West Lafayette), Dongsheng Gu(Indiana University – Purdue University Indianapolis), S S-Y Lee(Purdue University West Lafayette), Bao‐Liang Song(Purdue University West Lafayette), Shovik Bandyopadhyay(Purdue University West Lafayette), S Chen(Indiana University – Purdue University Indianapolis), Stephen F. Konieczny(Purdue University West Lafayette), Timothy L. Ratliff(Purdue University West Lafayette), Xiao Liu(Center for Cancer Research), Jingwu Xie(Indiana University Health), J-X Cheng(Purdue University West Lafayette)
Oncogene
May 2, 2016
Cited by 305Open Access
Full Text

Abstract

Cancer cells are known to execute reprogramed metabolism of glucose, amino acids and lipids. Here, we report a significant role of cholesterol metabolism in cancer metastasis. By using label-free Raman spectromicroscopy, we found an aberrant accumulation of cholesteryl ester in human pancreatic cancer specimens and cell lines, mediated by acyl-CoA cholesterol acyltransferase-1 (ACAT-1) enzyme. Expression of ACAT-1 showed a correlation with poor patient survival. Abrogation of cholesterol esterification, either by an ACAT-1 inhibitor or by shRNA knockdown, significantly suppressed tumor growth and metastasis in an orthotopic mouse model of pancreatic cancer. Mechanically, ACAT-1 inhibition increased intracellular free cholesterol level, which was associated with elevated endoplasmic reticulum stress and caused apoptosis. Collectively, our results demonstrate a new strategy for treating metastatic pancreatic cancer by inhibiting cholesterol esterification.


Related Papers

No related papers found

Powered by citation graph analysis